Background: Studies have linked the use of anti-secretory agents to nosocomial complications including Clostridium difficile–induced pseudomembranous colitis and hospital acquired pneumonia. In the outpatient setting, the Federal Drug Administration has issued warnings regarding increased risk of hypomagnesemia as well as fractures of the hip, wrist, and spine with the use of proton pump inhibitors. Although [...]